ALTHEADX, INC.

Profile

Company Names

ALTHEADX, INC.

Addresses

3030 BUNKER HILL STREET, SUITE 300, SAN DIEGO, CA 92109

10578 SCIENCE CENTER DRIVE, SUITE 100, SAN DIEGO, CA 92121

10578 SCIENCE CENTER DRIVE, SUITE 100, SAN DIEGO, CA 92121

3550 DUNHILL STREET, SAN DIEGO, CA 92121

Phone Numbers

858-882-0123
855-697-4943

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2008

State Incorporated:

DELAWARE

Total Amount Raised:

$51,834,741.00

Number of Funding Rounds:

12
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
12
2020-09-02 
$3,727,542.00 
$6,212,720.00 
$2,485,178.00 
Equity 
11
2019-09-23 
$1,320,353.00 
$1,700,023.00 
$379,670.00 
Equity 
10
2018-12-21 
$1,681,246.00 
$5,000,032.00 
$3,318,786.00 
Equity 
9
2018-07-27 
$1,971,927.00 
$5,000,038.00 
$3,028,111.00 
Equity 
8
2018-02-23 
$830,610.00 
$3,000,056.00 
$2,169,446.00 
Equity 
7
2017-02-01 
$3,000,001.00 
$15,000,001.00 
$12,000,000.00 
Equity 
6
2016-09-08 
$6,000,000.00 
$6,000,000.00 
$0.00 
Debt 
5
2016-07-01 
$2,221,227.00 
$6,000,000.00 
$3,778,773.00 
Debt 
4
2015-12-11 
$20,107,472.00 
$30,004,221.00 
$9,896,749.00 
Equity 
3
2014-03-31 
$150,000.00 
$300,000.00 
$150,000.00 
 
2
2013-05-30 
$7,249,849.00 
$7,249,849.00 
$0.00 
Equity 
1
2009-08-13 
$3,574,514.00 
$6,000,000.00 
$2,425,486.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
JEFFREY 
G. 
BLACK 
EXECUTIVE OFFICER
FENG 
 
CAO 
EXECUTIVE OFFICER
FRANCOIS 
 
FERRE 
DIRECTOR, EXECUTIVE OFFICER
JORGE 
 
GARCES 
EXECUTIVE OFFICER, DIRECTOR
JAMES 
 
GLAVIN 
DIRECTOR
JAMES 
GLAVIN 
DIRECTOR
GREG 
 
HAMILTON 
DIRECTOR, EXECUTIVE OFFICER
ANDREW 
 
JACKSON 
EXECUTIVE OFFICER
ANN 
 
KESSLER 
DIRECTOR
DEVAL 
LASHKARI 
DIRECTOR
JASON 
 
LIU 
DIRECTOR
MAGDA 
 
MARQUET 
EXECUTIVE OFFICER, DIRECTOR
JOSEPH 
 
MONFORTE 
EXECUTIVE OFFICER
DAVID 
 
NIKODEM 
EXECUTIVE OFFICER, DIRECTOR
CARIN 
 
SANDVIK 
EXECUTIVE OFFICER
YUH-GENG 
 
TSAY 
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D/A
BIOTECHNOLOGY 
SERVICES-MEDICAL LABORATORIES [8071] 
DECLINE TO DISCLOSE 
Equity 
2020-09-02 
D
BIOTECHNOLOGY 
SERVICES-MEDICAL LABORATORIES [8071] 
DECLINE TO DISCLOSE 
Equity 
2020-09-02 
D
BIOTECHNOLOGY 
SERVICES-MEDICAL LABORATORIES [8071] 
DECLINE TO DISCLOSE 
Equity 
2019-09-23 
D
BIOTECHNOLOGY 
SERVICES-MEDICAL LABORATORIES [8071] 
DECLINE TO DISCLOSE 
Equity 
2018-12-21 
D
BIOTECHNOLOGY 
SERVICES-MEDICAL LABORATORIES [8071] 
DECLINE TO DISCLOSE 
Equity 
2018-07-27 
D
BIOTECHNOLOGY 
SERVICES-MEDICAL LABORATORIES [8071] 
DECLINE TO DISCLOSE 
Equity 
2018-02-23 
D
BIOTECHNOLOGY 
SERVICES-MEDICAL LABORATORIES [8071] 
DECLINE TO DISCLOSE 
Equity 
2017-02-01 
D
BIOTECHNOLOGY 
SERVICES-MEDICAL LABORATORIES [8071] 
DECLINE TO DISCLOSE 
Debt 
2016-09-08 
D
BIOTECHNOLOGY 
SERVICES-MEDICAL LABORATORIES [8071] 
DECLINE TO DISCLOSE 
Debt 
2016-07-01 
D
BIOTECHNOLOGY 
SERVICES-MEDICAL LABORATORIES [8071] 
DECLINE TO DISCLOSE 
Equity 
2015-12-11 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
 
2014-03-31 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-05-30 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2009-08-13 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#